NxGen MDx
NxGen MDx is a privately held, Grand Rapids, Michigan-based women's health company founded in 2012 that delivers genetic screening services, operating with a reported headcount of 101-250 employees.
- Company typePrivate
- Founded2012
- HeadquartersGrand Rapids, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What NxGen MDx does
NxGen MDx is a privately held, for-profit women's health company headquartered in Grand Rapids, Michigan, founded in 2012. Its firmographic profile describes it as delivering 'highly accurate and precise genetic screening results,' positioning the company within the women's health genetic testing category — a domain that typically encompasses carrier screening, non-invasive prenatal testing (NIPT), hereditary cancer panels, and reproductive health-related assays. The company reports a headcount of 101-250 employees, indicating an established mid-size private operation rather than an early-stage venture.
The company's specific product surface, proprietary technology stack, assay platforms (e.g., NGS, microarrays, qPCR), genetic screening panels offered, sample collection logistics, and laboratory infrastructure are not documented in the available source data. The corporate website (nxgenmdx.com) returned a security/verification placeholder page ('One moment, please...') at the time of data collection rather than substantive product, technology, or operational content. No patents, trademarks, certifications, partnerships, or compliance credentials are recorded in the input material.
The business model and go-to-market mechanics are similarly underspecified. No pricing tiers, payer/insurance reimbursement dynamics, direct-to-consumer versus clinician-mediated ordering workflows, recurring screening programs, or revenue mechanics are described. There is no disclosed funding history, investor base, leadership bios, customer logos, or partnership relationships in the source material. As a result, the company's growth trajectory, financial scale, competitive positioning, and strategic posture cannot be independently verified beyond its basic firmographic identity, and any analytical claim beyond what is stated here is unsupported by the input.
NxGen MDx firmographics
Firmographics- Name
- NxGen MDx
- Website
- https://nxgenmdx.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- NxGen MDx is a privately held, Grand Rapids, Michigan-based women's health company founded in 2012 that delivers genetic screening services, operating with a reported headcount of 101-250 employees.
- Ownership category
- akta.pro rank
NxGen MDx industry classification
Industry- Product category
- Women's Health Genetic Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Companion Diagnostics (CDx) & Therapy Selection Assays (HLAAALAF)
Keywords
Where NxGen MDx is headquartered
LocationHeadquarters
- HQ city
- Grand Rapids
- HQ country
- United States
- HQ region
- North America
Markets served
NxGen MDx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
NxGen MDx product offering
Product offeringCore offering
NxGen MDx is a women's health company that delivers highly accurate and precise genetic screening results. The company develops and provides genetic screening tests aimed at supporting women's health, including reproductive and prenatal applications.
Product overview
No product information available from the source.
Differentiator
Problem solved
Functional benefit
Products and services
- Women's Health Genetic Screening Genetic screening tests delivered to women's health providers and patients with a focus on highly accurate and precise results.
Companies that use NxGen MDx
Customer profileIdeal customer profiles1 record
NxGen MDx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
NxGen MDx competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
NxGen MDx social profiles
Digital presenceNxGen MDx financial estimates
Financial estimateRevenue estimate
Valuation estimate
NxGen MDx leadership team
Management profileNumber of profiles
NxGen MDx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NxGen MDx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NxGen MDx
What does NxGen MDx do?
NxGen MDx is a women's health company that delivers highly accurate and precise genetic screening results. The company develops and provides genetic screening tests aimed at supporting women's health, including reproductive and prenatal applications.
When was NxGen MDx founded?
NxGen MDx was founded in 2012. It employs 101 to 250 people.
Where is NxGen MDx based?
NxGen MDx is headquartered in Grand Rapids, United States, in the North America region.
Does NxGen MDx have an API?
No public API is recorded for NxGen MDx.
What industry is NxGen MDx in?
NxGen MDx's product category is Women's Health Genetic Diagnostics. Its primary akta.pro industry code is HLAAALAF, Companion Diagnostics (CDx) & Therapy Selection Assays. Its NAICS code is 621511 and its SIC code is 8071.